Effect of endogenous estrogen on endothelial function in women with coronary heart disease and its mechanism

Clinica Chimica Acta

Volumn 339, Issue 1-2, 2004, Pages 183-188

  Li, Xiang Ping ^a   Zhou, Yan ^a   Zhao, Shui Ping ^a   Gao, Mei ^a   Zhou, Qi Chang ^a   Li, Yan Sheng ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

Asymmetric dimethylarginine; Coronary heart disease; Endothelium; Estrogen; Vasodilatation; Women

Indexed keywords

ESTRADIOL; N(G),N(G) DIMETHYLARGININE;

ADULT; ARTICLE; BRACHIAL ARTERY; CLINICAL ARTICLE; CONTROLLED STUDY; ENDOTHELIUM CELL; ESTRADIOL BLOOD LEVEL; ESTROGEN THERAPY; FEMALE; HEART DILATATION; HUMAN; ISCHEMIC HEART DISEASE; POSTMENOPAUSE; PRIORITY JOURNAL; REGULATORY MECHANISM;

EID: 0345734390     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cccn.2003.10.006     Document Type: Article

References (30)

1. La Vecchia C. Sex hormones and cardiovascular risk. Hum Reprod. 7:1992;162-167.
2. Gisclard V., Miller V.M., Vanhoutte P.M. Effect of 17 beta-estradiol on endothelium-dependent responses in the rabbit. J Pharmacol Exp Ther. 244:1988;19-22.
3. Williams J.K., Adams M.R., Klopfenstein H.S. Estrogen modulates responses of atherosclerotic coronary arteries. Circulation. 81:1990;1680-1687.
4. Herrington D.M., Braden G.A., Williams J.K., Morgan T.M. Endothelial-dependent coronary vasomotor responsiveness in postmenopausal women with and without estrogen replacement therapy. Am. J. Cardiol. 73:1994;951-952.
5. Barrett-Connor E., Grady D. Hormone replacement therapy, heart disease, and other considerations. Annu. Rev. Public Health. 19:1998;55-72.
6. Grady D., Herrington D., Bittner V.et al. Cardiovascular disease outcomes during 6.8 years of hormone therapy: Heart and Estrogen/Progestin Replacement Study follow-up (HERS II). J. Am. Med. Assoc. 288:2002;49-57.
7. Writing Group for the Women's Health Initiative Investigators Risk and benefits of estrogen plus progestin in healthy postmenopausal women. Principal results from the Women's Health Initiative randomized controlled trial. J. Am. Med. Assoc. 288:2002;321-333.
8. Moncada S., Higgs A. The L-arginine-nitric oxide pathway. N. Engl. J. Med. 329:1993;2002-2012.
9. Cayatte A.J., Palacino J.J., Horten K., Cohen R.A. Chronic inhibition of nitric oxide production accelerates neointima formation and impairs endothelial function in hypercholesterolemic rabbits. Arterioscler. Thromb. 14:1994;753-759.
10. Böger R.H., Bode-Böger S.M., Mügge A., Kienke S., Brandes R., Dwenger A.et al. Supplementation of hypercholesterolaemic rabbits with L-arginine reduces the vascular release of superoxide anions and restores NO production. Atherosclerosis. 117:1995;273-284.
11. Vallance P., Leone A., Calver A., Collier J., Moncada S. Endogenous dimethylarginine as an inhibitor of nitric oxide synthesis. J. Cardiovasc. Pharmacol. 20(suppl 12):1992;S60-S62.
12. Valkonen V.P., Paiva H., Salonen J.T., Lakka T.A., Lehtimaki T., Laaksoetal J.et al. Risk of acute coronary events and serum concentration of asymmetrical dimethylarginine. Lancet. 358:2001;2127-2128.
13. Post M.S., Verhoeven M.O., Mooren M.J.et al. Effect of hormone replacement therapy on plasma concentrations of the cardiovascular risk factor asymmetric dimethylarginine: a randomized, placebo-controlled 12-week study in healthy early postmenopausal women. J. Clin. Endocrinol. Metab. 88:2003;4221-4226.
14. Celermajer D.S., Sorensen K.E., Gooch V.M., Spiegelhalter D.J., Miller O.I., Sullivan I.D.et al. Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet. 340:1992;1111-1115.
15. G-dimethylarginine in human plasma by high-performance liquid chromatography. J. Chromatogr. 692:1997;467-471.
16. Ludmer P.L., Selwyn A.P., Shook T.L., Wayne R.R., Mudge G.H., Alexander R.W.et al. Paradoxical vasconstriction induced by acetylcholine in atherosclerotic coronary arteries. N. Engl. J. Med. 315:1986;1046-1051.
17. Li X.P., Zhao S.P., Zhang X.Y., Liu L., Gao M., Zhou Q.C. Protective effect of high density lipoprotein on endothelium-dependent vasodilatation. Int. J. Cardiol. 73:2000;231-236.
18. Adams M.R., Robinson J., McCredie R.et al. Smooth muscle dysfunction occurs independently of impaired endothelium-dependent dilation in adults at risk of atherosclerosis. J. Am. Coll. Cardiol. 32(1):1998;123-127.
19. Zhang X.Y., Zhao S.P., Li X.P.et al. Endothelium-dependent and -independent functions are impaired in patients with coronary heart disease. Atherosclerosis. 149(1):2000;19-24.
20. Hashimoto M., Akishita M., Eto M., Ishikawa M., Kozaki K., Toba K.et al. Modulation of endothelium-dependent flow-mediated dilation of the brachial artery by sex and menstrual cycle. J. Am. Coll. Cardiol. 92:1995;3431-3435.
21. Dorup I., Skajaa K., Sorensen K.E. Normal pregnancy is associated with enhanced endothelium-dependent flow-mediated vasodilation. Am. J. Physiol. 276:1999;H821-H825.
22. Celermajer D.S., Sorensen K.E., Spiegelhalter D.J., Georgakopoulos D., Robinson J., Deanfield J.E. Aging is associated with endothelial dysfunction in healthy men years before the age-related decline in women. J. Am. Coll. Cardiol. 24:1994;471-476.
23. Reis S.E., Gloth S.T., Blumenthal R.S., Resar J.R., Zacur H.A., Gerstenblith G.et al. Ethinyl estradiol acutely attenuates abnormal coronary vasomotor responses to acetylcholine in postmenopausal women. Circulation. 89:1994;52-60.
24. Gilligan D.M., Badar D.M., Panza J.A., Quyyumi A.A., Cannon R.O. Effects of estrogen replacement therapy on peripheral vasomotor function in postmenopausal women. Am. J. Cardiol. 75:1995;264-268.
25. Al-Khalili F., Eriksson M., Landgren B.M., Schenck-Gustafsson K. Effect of conjugated estrogen on peripheral flow-mediated vasodilation in postmenopausal women. Am. J. Cardiol. 82:1998;215-218.
26. Greiner D.Z., Personius B.E., Andrews T.C. Effects of withdrawal of chronic estrogen therapy on brachial artery vasoreactive in women with coronary artery disease. Am. J. Cardiol. 83:1999;247-249.
27. Böger R.H., Bode-Böger S.M., Tsao P.S., Lin P.S., Chan J.R., Cooke J.P. An endogenous inhibitor of nitric oxide synthase regulates endothelial adhesiveness for monocytes. J. Am. Coll. Cardiol. 36:2000;2287-2295.
28. Böger R.H., Bode-Böger S.M., Szuba A., Tsao P.S., Chan J.R., Targphaoetal O.et al. Asymmetric dimethylarginine(ADMA): a novel risk factor for endothelial dysfunction - its role in hyper-cholesterolemia. Circulation. 98:1998;1842-1847.
29. Herrington D.M., Braden G.A., Williams J.K., Morgan T.M. Endothelial-dependent coronary vasomotor responsiveness in postmenopausal women with and without estrogen replacement therapy. Am. J. Cardiol. 73:1994;951-952.
30. Valkonen V.P., Paiva H., Salonen J.T., Lakka T.A., Lehtimaki T., Laakso J.et al. Risk of acute coronary events and serum concentration of asymmetrical dimethylarginine. Lancet. 358:2001;2127-2128.